IDEXX Laboratories, Inc. (IDXX) stock analysis

In our weekly check, IDEXX Laboratories, Inc. is graded A (A to F). Of 24 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 1.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as IDXX.

What our checks show for IDXX

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-01

Similar companies

A · NTRA · WAT · IQV · MTD · ILMN

Questions

What grade does IDEXX Laboratories, Inc. (IDXX) have?

In our weekly check, IDEXX Laboratories, Inc. is graded A (A to F). Of 24 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of IDXX stock?

This week's biggest flags for IDEXX Laboratories, Inc.: Deep past fall, High P/E, Very volatile. In total 4 of 24 checks show a warning or a red flag.

What does IDEXX Laboratories, Inc. do?

IDEXX Laboratories, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as IDXX.

When does IDEXX Laboratories, Inc. report earnings next?

The next earnings report is expected on 2027-02-01. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis